ARTELO BIOSCIENCES, INC. - 10-Q Filing
Artelo Biosciences reports $4.4M cash position for Q3 2026 with total assets increasing to $6.7M.
Tickers: $ARTL
More Regulatory news
- FILANA THERAPEUTICS, INC. - 8-K Filing
- RUM Group Inc. - 8-K Filing
- Theriva Biologics, Inc. - 10-Q Filing
- SeaStar Medical Holding Corp - 10-Q Filing
- Avalyn Pharma Inc. - 10-Q Filing
- SES AI Corp - 8-K Filing
- Data443 Risk Mitigation, Inc. - 8-K Filing
- TRUSTMARK CORP - 8-K Filing
- SUBURBAN PROPANE PARTNERS LP - 8-K Filing
- MeiraGTx Holdings plc - 10-Q Filing